Febrile Neutropenia: all 147 studies
Page 1 of 2. Open to participants first (36), then studies with results posted, then the rest; newest registration first within each.
- Diagnostic Accuracy, Clinical Utility and Implementation of Point-of-Care Absolute Neutrophil Count in Suspected Neutropenic Fever (DUCATIS) - Diagnostic Accuracy (S1)Not yet recruitingNCT07901660Not applicable
- Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast CancerRecruitingNCT07899099
- Restrictive Versus Standard Antibiotic Treatment During CAR-T TherapyNot yet recruitingNCT07842198Phase 2
- Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSFNot yet recruitingNCT07806084
- Phase II Study of QLC2519 in Pediatric Solid Tumor ParticipantsRecruitingNCT07724756Phase 2
- Early Discontinuation of Antibiotics in Paediatric High-risk Febrile NeutropeniaNot yet recruitingNCT07590648Phase 4
- Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.Not yet recruitingNCT07483736Phase 3
- Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia PatientsRecruitingNCT07372131Not applicable
- Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile NeutropeniaRecruitingNCT07277387
- Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor ChemoradiotherapyRecruitingNCT07205536Phase 2
- Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.RecruitingNCT07204522
- Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FNRecruitingNCT07187908Phase 2
- Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and FeverRecruitingNCT07051525Not applicable
- Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic MalignanciesRecruitingNCT07016165Phase 4
- Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile NeutropeniaNot yet recruitingNCT06988826Phase 4
- Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)Not yet recruitingNCT06794320Not applicable
- Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced NeutropeniaNot yet recruitingNCT06697262Not applicable
- Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma PatientsNot yet recruitingNCT06665737Phase 4
- Compare the Efficacy and Safety of QL0605 Injections at Different TimepointsRecruitingNCT06616571Phase 4
- Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With SarcomaNot yet recruitingNCT06500715Not applicable
- PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy ComplicationsNot yet recruitingNCT06450821Not applicable
- Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing PathogensRecruitingNCT06342115Phase 4
- Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal ClearanceRecruitingNCT06293677Phase 4
- Early Neutropenic Fever De-escalation of Antibiotics StudyNot yet recruitingNCT06278896Phase 3
- A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk FactorsNot yet recruitingNCT06143735Phase 2
- Lapelga vs GastrofilNot yet recruitingNCT06116734Phase 3
- Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals.Not yet recruitingNCT05852249
- Next-Generation-Sequencing Approach to Neutropenic SepsisRecruitingNCT05815628
- Short Antibiotic Treatment in High Risk Febrile NeutropeniaRecruitingNCT05786495Not applicable
- Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia PatientsNot yet recruitingNCT05665478Not applicable
- Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell TherapyNot yet recruitingNCT05576220Not applicable
- Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against InfectionRecruitingNCT05393505Phase 4
- A Trial of Fosfomycin vs Ciprofloxacin for Febrile NeutropeniaRecruitingNCT05311254Phase 3
- New Diagnostics in NeutropeniaRecruitingNCT05174546
- Early De-escalation of Empirical Antibiotics Treatment for Neutropenic FeverRecruitingNCT04270786Not applicable
- Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & NeutropeniaRecruitingNCT02536599
- Fluoroquinolone Resistance Prevalence StudyTerminatedNCT05824689Results posted
- Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled SyringeCompletedNCT05194579Phase 1Results posted
- Feasibility of Monitoring Health Data in Pediatric Patients Undergoing ChemotherapyCompletedNCT04134429Results posted
- Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast CancerCompletedNCT03104595Phase 1/2Results posted
- Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With CancerTerminatedNCT02732327Phase 2Results posted
- S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
- Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer PatientsCompletedNCT02104830Phase 3Results posted
- A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT01619423Phase 1/2Results posted
- Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast CancerCompletedNCT01569087Phase 2Results posted
- Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorCompletedNCT01459653Results posted
- Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic PatientsCompletedNCT01401010Phase 4Results posted
- Daptomycin Versus Placebo in Patients With Neutropenia and FeverTerminatedNCT01216241Phase 3Results posted
- Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical OptionsCompletedNCT00945555Results posted
- PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyCompletedNCT00911170Phase 3Results posted
- Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and NeutropeniaCompletedNCT00723073Results posted
- Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer PatientsActive, not recruitingNCT07690956Not applicable
- Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction PhaseTerminatedNCT07320534Phase 4
- Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction ChemotherapyCompletedNCT07113314Not applicable
- Human Bioequivalence Study of Liposomal Amphotericin B for InjectionCompletedNCT06983665Not applicable
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionCompletedNCT06977490Not applicable
- A Comparative Evaluation of Pharmacokinetics and Immunogenicity.CompletedNCT06918587Phase 1
- Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile NeutropeniaActive, not recruitingNCT06787326
- ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving ChemotherapyCompletedNCT06657183Not applicable
- A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid MalignanciesWithdrawnNCT06254742Phase 3
- Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile NeutropeniaCompletedNCT05926063Phase 4
- Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of PegfilgrastimCompletedNCT05910164
- AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic PatientsCompletedNCT05793073
- Antimicrobial Revision in Persistent Febrile NeutropeniaWithdrawnNCT05784844Phase 4
- Pharmacokinetics and Safety of AmBisome and DKF-5122CompletedNCT05749380Phase 1
- Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological DisorderCompletedNCT05689450
- Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)CompletedNCT05584930Not applicable
- Impact of Computerized Decision Support for ANTIBIOtic Prescription in Cancer Patients With Febrile NEutropenia in the Emergency Department on Treatment Failure.Status unknownNCT05206006Not applicable
- Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignanciesStatus unknownNCT05203809
- mNGS Versus Blood Culture in FNStatus unknownNCT05149547
- Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT05133310Phase 4
- CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology PatientsWithdrawnNCT05061654Phase 4
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedNCT04948463Phase 4
- DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision RuleTerminatedNCT04938206Not applicable
- Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.CompletedNCT04914702
- Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile NeutropeniaCompletedNCT04910698
- Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncologyStatus unknownNCT04758442Not applicable
- Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.WithdrawnNCT04698057Phase 3
- Host RNA Signature in Children With Cancer and InfectionCompletedNCT04669418
- An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving UdenycaStatus unknownNCT04662892
- Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With CancerCompletedNCT04637464Not applicable
- Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer ChemotherapyCompletedNCT04477616Phase 2
- Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving ChemotherapyCompletedNCT04466137Phase 3
- Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FNCompletedNCT04460079
- Remote Monitoring of Patients at Risk of SepsisWithdrawnNCT04260230Not applicable
- Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile NeutropeniaStatus unknownNCT04250038
- Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic PatientsStatus unknownNCT04233996Phase 4
- Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic FeverCompletedNCT04187755Phase 4
- Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled TrialCompletedNCT04099901Phase 2
- Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile NeutropeniaCompletedNCT04000711Not applicable
- Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever PatientsCompletedNCT03968328
- G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer PatientsStatus unknownNCT03793205Phase 4
- Long-acting G-CSF for Febrile NeutropeniaStatus unknownNCT03740464Phase 3
- Ampholipad Real-World Data in TaiwanCompletedNCT03641131
- Pneumococcal Vaccination of Multiple Myeloma Patients on Novel AgentsCompletedNCT03619252Phase 4
- Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast CancerStatus unknownNCT03618810
- A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent FeverCompletedNCT03511820
- Pentaglobin in CRE and PA Neutropenic InfectionsActive, not recruitingNCT03494959Phase 2
- Efficacy of Oral Supplementation With Magnesium to Reduce Febrile NeutropeniaStatus unknownNCT03449693Phase 2
- Distinction Risk of Severe Infection in Febrile Neutropenia After ChemotherapyCompletedNCT03434795